Growth Metrics

Mannkind (MNKD) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.71%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 31.42%
10 Mannkind 1.09 Bn 956.66 Mn 82.66 Mn -63.78%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -63.78%
Dec 31, 2025 3.15%
Sep 30, 2025 42.43%
Jun 30, 2025 31.40%
Mar 31, 2025 33.98%
Dec 31, 2024 58.32%
Sep 30, 2024 38.42%
Jun 30, 2024 26.11%
Mar 31, 2024 33.28%
Dec 31, 2023 344.44%
Sep 30, 2023 62.97%
Jun 30, 2023 -72.10%
Mar 31, 2023 51.52%
Dec 31, 2022 -4.54%
Sep 30, 2022 19.07%
Jun 30, 2022 -12.91%
Mar 31, 2022 -25.23%
Dec 31, 2021 -31.88%
Sep 30, 2021 -13.36%
Jun 30, 2021 7.26%
Mar 31, 2021 14.13%
Dec 31, 2020 79.40%
Sep 30, 2020 16.67%
Jun 30, 2020 41.79%
Mar 31, 2020 -49.22%
Dec 31, 2019 16.33%
Sep 30, 2019 -30.66%
Jun 30, 2019 -20.72%
Mar 31, 2019 28.08%
Dec 31, 2018 45.70%
Sep 30, 2018 12.98%
Jun 30, 2018 -6.71%
Mar 31, 2018 -163.53%
Dec 31, 2017 9.69%
Sep 30, 2017 -31.16%
Jun 30, 2017 14.16%
Mar 31, 2017 30.48%
Dec 31, 2016 31.81%
Sep 30, 2016 11.37%
Jun 30, 2016 27.24%
Mar 31, 2016 1.60%
Dec 31, 2015 6.71%
Sep 30, 2015 14.99%
Jun 30, 2015 3.86%
Mar 31, 2015 66.96%
Dec 31, 2014 -25.67%
Sep 30, 2014 64.83%
Jun 30, 2014 8.14%
Mar 31, 2014 -5.50%
Dec 31, 2013 2.14%
Sep 30, 2013 3.08%